Literature DB >> 26864266

High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy.

Katherine H Parker1, Lucas A Horn1, Suzanne Ostrand-Rosenberg2.   

Abstract

Myeloid-derived suppressor cells are immune-suppressive cells that are elevated in most individuals with cancer, where their accumulation and suppressive activity are driven by inflammation. As myeloid-derived suppressor cells inhibit anti-tumor immunity and promote tumor progression, we are determining how their viability is regulated. Previous studies have established that the damage-associated molecular pattern molecule high-mobility group box protein 1 drives myeloid-derived suppressor cell accumulation and suppressive potency and is ubiquitously present in the tumor microenvironment. As high-mobility group box protein 1 also facilitates tumor cell survival by inducing autophagy, we sought to determine if high-mobility group box protein 1 regulates myeloid-derived suppressor cell survival through induction of autophagy. Inhibition of autophagy increased the quantity of apoptotic myeloid-derived suppressor cells, demonstrating that autophagy extends the survival and increases the viability of myeloid-derived suppressor cells. Inhibition of high-mobility group box protein 1 similarly increased the level of apoptotic myeloid-derived suppressor cells and reduced myeloid-derived suppressor cell autophagy, demonstrating that in addition to inducing the accumulation of myeloid-derived suppressor cells, high-mobility group box protein 1 sustains myeloid-derived suppressor cell viability. Circulating myeloid-derived suppressor cells have a default autophagic phenotype, and tumor-infiltrating myeloid-derived suppressor cells are more autophagic, consistent with the concept that inflammatory and hypoxic conditions within the microenvironment of solid tumors contribute to tumor progression by enhancing immune-suppressive myeloid-derived suppressor cells. Overall, these results demonstrate that in addition to previously recognized protumor effects, high-mobility group box protein 1 contributes to tumor progression by increasing myeloid-derived suppressor cell viability by driving them into a proautophagic state. © Society for Leukocyte Biology.

Entities:  

Keywords:  DAMPs; tumor microenvironment; tumor-induced immune suppression

Mesh:

Substances:

Year:  2016        PMID: 26864266      PMCID: PMC4982609          DOI: 10.1189/jlb.3HI0715-305R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  42 in total

1.  Growth factor regulation of autophagy and cell survival in the absence of apoptosis.

Authors:  Julian J Lum; Daniel E Bauer; Mei Kong; Marian H Harris; Chi Li; Tullia Lindsten; Craig B Thompson
Journal:  Cell       Date:  2005-01-28       Impact factor: 41.582

2.  Endoplasmic reticulum stress triggers autophagy.

Authors:  Tomohiro Yorimitsu; Usha Nair; Zhifen Yang; Daniel J Klionsky
Journal:  J Biol Chem       Date:  2006-08-10       Impact factor: 5.157

Review 3.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

4.  Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice.

Authors:  Tangying Lu; Rupal Ramakrishnan; Soner Altiok; Je-In Youn; Pingyan Cheng; Esteban Celis; Vladimir Pisarev; Simon Sherman; Michael B Sporn; Dmitry Gabrilovich
Journal:  J Clin Invest       Date:  2011-09-12       Impact factor: 14.808

5.  ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.

Authors:  Thomas Condamine; Vinit Kumar; Indu R Ramachandran; Je-In Youn; Esteban Celis; Niklas Finnberg; Wafik S El-Deiry; Rafael Winograd; Robert H Vonderheide; Nickolas R English; Stella C Knight; Hideo Yagita; Judith C McCaffrey; Scott Antonia; Neil Hockstein; Robert Witt; Gregory Masters; Thomas Bauer; Dmitry I Gabrilovich
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

6.  Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.

Authors:  Pratima Sinha; Olesya Chornoguz; Virginia K Clements; Konstantin A Artemenko; Roman A Zubarev; Suzanne Ostrand-Rosenberg
Journal:  Blood       Date:  2011-03-30       Impact factor: 22.113

7.  High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress.

Authors:  Daolin Tang; Rui Kang; Kristen M Livesey; Herbert J Zeh; Michael T Lotze
Journal:  Antioxid Redox Signal       Date:  2011-06-06       Impact factor: 8.401

8.  TNF signaling drives myeloid-derived suppressor cell accumulation.

Authors:  Xueqiang Zhao; Lijie Rong; Xiaopu Zhao; Xiao Li; Xiaoman Liu; Jingjing Deng; Hao Wu; Xia Xu; Ulrike Erben; Peihua Wu; Uta Syrbe; Joachim Sieper; Zhihai Qin
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

Review 9.  Role of autophagy in cancer.

Authors:  Robin Mathew; Vassiliki Karantza-Wadsworth; Eileen White
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

10.  Lysosomal basification and decreased autophagic flux in oxidatively stressed trabecular meshwork cells: implications for glaucoma pathogenesis.

Authors:  Kristine Porter; Jeyabalan Nallathambi; Yizhi Lin; Paloma B Liton
Journal:  Autophagy       Date:  2013-01-29       Impact factor: 16.016

View more
  28 in total

1.  Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells.

Authors:  Alyssa D Smith; Chunwan Lu; Daniela Payne; Amy V Paschall; John D Klement; Priscilla S Redd; Mohammed L Ibrahim; Dafeng Yang; Qimei Han; Zhuoqi Liu; Huidong Shi; Thomas J Hartney; Asha Nayak-Kapoor; Kebin Liu
Journal:  Cancer Res       Date:  2020-06-17       Impact factor: 12.701

Review 2.  Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation.

Authors:  Brent H Koehn; Bruce R Blazar
Journal:  J Leukoc Biol       Date:  2017-02-01       Impact factor: 4.962

3.  Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.

Authors:  Themis Alissafi; Aikaterini Hatzioannou; Konstantinos Mintzas; Roza Maria Barouni; Aggelos Banos; Sundary Sormendi; Alexandros Polyzos; Maria Xilouri; Ben Wielockx; Helen Gogas; Panayotis Verginis
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

Review 4.  Autophagy in tumour immunity and therapy.

Authors:  Houjun Xia; Douglas R Green; Weiping Zou
Journal:  Nat Rev Cancer       Date:  2021-03-23       Impact factor: 60.716

5.  Evaluation of autophagy mediators in myeloid-derived suppressor cells during human tuberculosis.

Authors:  Leigh A Kotze; Vinzeigh N Leukes; Zhuo Fang; Manfred B Lutz; Bryna L Fitzgerald; John Belisle; Andre G Loxton; Gerhard Walzl; Nelita du Plessis
Journal:  Cell Immunol       Date:  2021-08-24       Impact factor: 4.178

Review 6.  Cancer Cachexia and Antitumor Immunity: Common Mediators and Potential Targets for New Therapies.

Authors:  Konstantinos Rounis; Dimitrios Makrakis; Ioannis Gioulbasanis; Simon Ekman; Luigi De Petris; Dimitris Mavroudis; Sofia Agelaki
Journal:  Life (Basel)       Date:  2022-06-12

7.  Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade.

Authors:  Eric T Alexander; Kelsey Mariner; Julia Donnelly; Otto Phanstiel; Susan K Gilmour
Journal:  Mol Cancer Ther       Date:  2020-08-03       Impact factor: 6.261

Review 8.  Survival of the fittest: how myeloid-derived suppressor cells survive in the inhospitable tumor microenvironment.

Authors:  Suzanne Ostrand-Rosenberg; Daniel W Beury; Katherine H Parker; Lucas A Horn
Journal:  Cancer Immunol Immunother       Date:  2019-09-09       Impact factor: 6.968

9.  Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.

Authors:  Huabin Zhu; John D Klement; Chunwan Lu; Priscilla S Redd; Dafeng Yang; Alyssa D Smith; Dakota B Poschel; Juan Zou; Ding Liu; Peng George Wang; David Ostrov; Nicolas Coant; Yusuf A Hannun; Aaron H Colby; Mark W Grinstaff; Kebin Liu
Journal:  J Immunol       Date:  2021-02-05       Impact factor: 5.422

10.  Intralesional injection of rose bengal augments the efficacy of gemcitabine chemotherapy against pancreatic tumors.

Authors:  Patrick Innamarato; Jennifer Morse; Amy Mackay; Sarah Asby; Matthew Beatty; Jamie Blauvelt; Scott Kidd; John E Mullinax; Amod A Sarnaik; Shari Pilon-Thomas
Journal:  BMC Cancer       Date:  2021-06-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.